Gallo V, Giovannini C, Levi G
Neurobiology Section, Istituto Superiore di Sanità, Rome, Italy.
J Neurochem. 1990 May;54(5):1619-25. doi: 10.1111/j.1471-4159.1990.tb01213.x.
Kainic acid (KA), quisqualic acid (QUIS), and alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) stimulated D-[3H]aspartate release from cultured cerebellar granule cells in a concentration-dependent way. The EC50 values were 50 microM for KA (Gallo et al., 1987) and 20 microM for both QUIS and AMPA, but the efficacy of QUIS appeared to be greater than that of AMPA. The release of D-[3H]aspartate induced by KA, QUIS, and AMPA was blocked, in a dose-dependent way, by the new glutamate receptor antagonist 6-cyano-2,3-dihydroxy-7-nitroquinoxaline (CNQX); IC50 values were 0.7 microM in the case of AMPA (50 microM) and 1 microM in the case of KA (50 microM). AMPA (50-300 microM) inhibited the effect of 50 microM KA on D-[3H]aspartate release. At 300 microM AMPA, the effect of KA plus AMPA was not antagonized by the KA receptor antagonist kynurenic acid (KYN). In contrast, when KA was used at an ineffective concentration (10 microM), the addition of AMPA at concentrations below the EC50 value (10-20 microM) resulted in a synergistic effect on D-[3H]aspartate release. In this case, the evoked release of D-[3H]aspartate was sensitive to KYN. KA stimulated the formation of cyclic GMP, whereas QUIS, AMPA, and glutamate were ineffective. The accumulation of cyclic GMP elicited by KA (100 microM) was prevented not only by the antagonists CNQX (IC50 = 1.5 microM) and KYN (IC50 = 200 microM), but also by the agonists AMPA (IC50 = 50 microM) QUIS (IC50 = 3.5 microM), and glutamate (IC50 = 100 microM). We conclude that AMPA, like QUIS, may act as a partial agonist at KA receptors. Moreover, CNQX effectively antagonizes non-N-methyl-D-aspartate receptor-mediated responses in cultured cerebellar granule cells.
海人酸(KA)、喹啉酸(QUIS)和α-氨基-3-羟基-5-甲基-4-异恶唑丙酸(AMPA)能以浓度依赖的方式刺激培养的小脑颗粒细胞释放D-[3H]天冬氨酸。KA的半数有效浓度(EC50)值为50微摩尔(加洛等人,1987年),QUIS和AMPA的EC50值均为20微摩尔,但QUIS的效力似乎高于AMPA。KA、QUIS和AMPA诱导的D-[3H]天冬氨酸释放被新型谷氨酸受体拮抗剂6-氰基-2,3-二羟基-7-硝基喹喔啉(CNQX)以剂量依赖的方式阻断;AMPA(50微摩尔)情况下的半数抑制浓度(IC50)值为0.7微摩尔,KA(50微摩尔)情况下的IC50值为1微摩尔。AMPA(50 - 300微摩尔)抑制50微摩尔KA对D-[3H]天冬氨酸释放的作用。在300微摩尔AMPA时,KA加AMPA的作用未被KA受体拮抗剂犬尿喹啉酸(KYN)拮抗。相反,当KA以无效浓度(10微摩尔)使用时,添加低于EC50值(10 - 20微摩尔)的AMPA会对D-[3H]天冬氨酸释放产生协同作用。在这种情况下,诱发的D-[3H]天冬氨酸释放对KYN敏感。KA刺激环鸟苷酸(cGMP)的形成,而QUIS、AMPA和谷氨酸则无此作用。KA(100微摩尔)引起的cGMP积累不仅被拮抗剂CNQX(IC50 = 1.5微摩尔)和KYN(IC50 = 200微摩尔)阻止,也被激动剂AMPA(IC50 = 50微摩尔)、QUIS(IC50 = 3.5微摩尔)和谷氨酸(IC50 = 100微摩尔)阻止。我们得出结论,AMPA与QUIS一样,可能在KA受体上作为部分激动剂起作用。此外,CNQX能有效拮抗培养的小脑颗粒细胞中非N-甲基-D-天冬氨酸受体介导的反应。